Showing 7041-7050 of 20410 results for "".
Key Considerations for G-CSF Administration in Patients with FN Risk
https://reachmd.com/programs/medical-industry-feature/key-considerations-for-g-csf-administration-in-patients-with-fn-risk/13123/Here’s what you need to keep in mind when administering granulocyte colony stimulating factors for primary prophylaxis of febrile neutropenia.Advice to the Healer: On the Art of Caring
https://reachmd.com/programs/book-club/advice-to-the-healer-on-the-art-of-caring/6956/The healing professions have an ancient and venerable tradition of service, honor, and humanism that is often communicated from teacher to student in anecdotes and bits of wisdom told quickly in passing. In his book, Advice to the Healer: On the Art of Caring, Dr. Richard Colgan, Professor of FamilyGood and Bad Dietary Fats Explained
https://reachmd.com/programs/lipid-luminations/good-and-bad-dietary-fats-explained/3942/For most Americans, the ratio of omega-6 to omega-3 fatty acids in their diet is about sixteen to one, an unhealthy ratio that promotes chronic diseases from heart disease to macular degeneration to colitis. Worse, omega-6s can counteract the beneficial effects of omega-3s. Dr. Seth Baum, medical diA Successful and Safe Stem Cell Therapy for Progressive MS
https://reachmd.com/programs/neurofrontiers/a-successful-and-safe-stem-cell-therapy-for-progressive-ms/17928/Dive into the phase 1 study that was successful in showing stem cell therapy for people with active and nonactive progressive MS is doable.The Collateral Damage of “Non-Essential” Procedure Designations
https://reachmd.com/programs/covid-19-frontlines/collateral-damage-non-essential-procedure-designations/11377/Are the delays and cancellations of non-emergent surgeries and procedures creating new ramifications for patient health that may be felt for years?GeneHarmony: Mapping Shared Genes in Autoimmune Disease
https://reachmd.com/programs/living-rheum/geneharmony-mapping-shared-genes-in-autoimmune-disease/36344/Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
https://reachmd.com/programs/heart-matters/plasma-biomarkers-hf-hospitalization-atrial-fibrillation/54805/Evolving Treatments: A Review of What’s in the Pipeline
https://reachmd.com/programs/lipid-luminations/evolving-treatments-a-review-of-whats-in-the-pipeline/6630/Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in todOptimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
https://reachmd.com/programs/clinicians-roundtable/optimizing-colorectal-cancer-screening-a-stress-test-of-current-guidelines/36408/Conflicting colorectal cancer screening (CRC) guidelines have sometimes led to confusion over optimal starting ages and strategies. Join Dr. Pedro Nascimento de Lima as he walks through a comprehensive modeling study that tested 26 different strategies over 4,000 scenarios to test how and when it isReviewing the Treatment Landscape for Duchenne Muscular Dystrophy
https://reachmd.com/programs/neurofrontiers/reviewing-the-treatment-landscape-for-duchenne-muscular-dystrophy/16066/Although there is currently no cure, what treatment options are available for our patients with Duchenne muscular dystrophy?